Editas Medicine Insider Trades
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 14 · $106.73K
- Shares bought / sold
- 0 / 41.86K
- Net activity
- Net selling $106,725
Editas Medicine insider activity
Over the last 12 months, Editas Medicine insiders reported 14 transactions on SEC Form 4: 0 open-market purchases and 14 sales. Insiders bought $0 and sold $106,725 worth of stock, for net insider selling of $106,725. The largest seller was O'Neill Gilmore Neil, with $80,064 in reported sales.
The most recent filing shows Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) selling 709 shares at $3.04 on Sep 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EDIT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
EDIT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 3, 2026 | Parison AmySVP, Chief Financial Officer | Sale | 453 | $1.38K | Form 4 |
| Sep 3, 2026 | O'Neill Gilmore NeilCEO | Sale | 5,124 | $15.56K | Form 4 |
| Sep 3, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 709 | $2.15K | Form 4 |
| Aug 3, 2026 | Parison AmySVP, Chief Financial Officer | Sale | 678 | $1.75K | Form 4 |
| Jul 28, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 4,928 | $13.16K | Form 4 |
| Jun 3, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 731 | $1.97K | Form 4 |
| Jun 3, 2026 | Parison AmySVP, Chief Financial Officer | Sale | 464 | $1.25K | Form 4 |
| Jun 3, 2026 | O'Neill Gilmore NeilCEO | Sale | 15,380 | $41.54K | Form 4 |
| Mar 3, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 749 | $1.51K | Form 4 |
| Mar 3, 2026 | O'Neill Gilmore NeilCEO | Sale | 5,394 | $10.89K | Form 4 |
| Mar 3, 2026 | Parison AmySVP, Chief Financial Officer | Sale | 474 | $957.48 | Form 4 |
| Dec 3, 2025 | Parison AmySVP, Chief Financial Officer | Sale | 461 | $992.58 | Form 4 |
| Dec 3, 2025 | O'Neill Gilmore NeilCEO | Sale | 5,603 | $12.06K | Form 4 |
| Dec 3, 2025 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 713 | $1.54K | Form 4 |
| Sep 3, 2025 | Parison AmySVP, Chief Financial Officer | Sale | 458 | $1.19K | Form 4 |
| Sep 3, 2025 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 710 | $1.84K | Form 4 |
| Sep 3, 2025 | O'Neill Gilmore NeilCEO | Sale | 5,592 | $14.52K | Form 4 |
| Aug 7, 2025 | Parison AmySVP, Chief Financial Officer | Sale | 679 | $1.75K | Form 4 |
| Jul 31, 2025 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 5,121 | $12.76K | Form 4 |
| Jun 3, 2025 | O'Neill Gilmore NeilCEO | Sale | 15,192 | $26.20K | Form 4 |
| Jun 3, 2025 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sale | 726 | $1.25K | Form 4 |
| Jun 3, 2025 | Parison AmySVP, Chief Financial Officer | Sale | 446 | $768.90 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4